Patient Controlled Self-Administration of Oral Liquid Medication: Acetaminophen Trial
Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This is a proof of concept pilot study investigating the feasibility and acceptability of patient controlled oral medication administration, using the commonly used and low risk medication in the hospital, oral acetaminophen.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
⁃ Participants
• Adult patients older than 18 years old admitted to SRC for total shoulder and reverse total shoulder arthroplasty
⁃ Nurses
• The nurse who will administer acetaminophen to a study patient.
Locations
United States
Connecticut
Yale New Haven Hospital at St. Raphael's Campus
RECRUITING
New Haven
Contact Information
Primary
Jinlei Li, MD, PhD
jinlei.li@yale.edu
475-434-4038
Time Frame
Start Date: 2024-11-19
Estimated Completion Date: 2025-08
Participants
Target number of participants: 24
Treatments
Active_comparator: Nurse Administered Acetaminophen
Participants will receive acetaminophen pills 650 mg every 4 hours as needed (PRN) administered by nurse per standard of care
Experimental: CADD pump Administered Acetaminophen (Participant Controlled)
Participants will receive a CADD pump primed and programmed to deliver 650 mg liquid acetaminophen into a medication cup every 4 hours as needed (PRN).
Related Therapeutic Areas
Sponsors
Leads: Yale University